Investing Ideas
/
Canadian Pharmaceuticals & Biotech Undervalued based on future growth

Canadian Pharmaceuticals & Biotech Undervalued based on future growth

Name: Financial Insights Based on S&P Global Market Intelligence
Creator: Simply Wall St Pty Ltd
License: https://www.spglobal.com/content/dam/spglobal/corporate/en/documents/secure/MI-FastTrack-Terms-and-Conditions-July-2023.pdf

Results

0 new

Companies which can be considered undervalued when accounting for expected future growth (PEG under 0.8)

1 companies

Decibel Cannabis

Market Cap: CA$54.8m

An integrated cannabis company, engages in the cannabis cultivation in Canada.

CA$0.095

5.6%

35.7%